Hormonal
Semaglutide (2.4 mg weekly) produces significant weight loss (10-15%) in adults with obesity by slowing gastric emptying and reducing appetite, but discontinuation leads to substantial weight regain, necessitating continuous treatment.
Semaglutide 2.4mg weekly is a highly effective tool for significant weight loss (10-15%) in obesity, working by reducing appetite and slowing digestion. However, it is not a cure; stopping the medication typically leads to regaining most of the lost weight. It works best when combined with lifestyle changes and requires ongoing medical supervision to manage side effects like nausea and to ensure long-term success.
A semaglutida, um agonista do receptor GLP-1, demonstrou redução média de peso corporal entre 10% e 15% em diversos estudos, atuando na diminuição do apetite e aumento da saciedade. [...] após a interrupção do tratamento, essas melhorias não foram mantidas, e na semana 120, a maioria das variáveis retornaram aos níveis iniciais oferecidos, revertendo, em média, 11,6% do peso que perderam.
Why this rating
Based on multiple randomized controlled trials (STEP 1, STEP 4) and meta-analyses cited in the review.
Source
Vantagens da utilização da semaglutida no tratamento de obesidade e sobrepeso - Uma revisão de literatura
Emanuelle Luisa Fiorese et al. · Research Society and Development · 2024
DOI 10.33448/rsd-v13i11.47456
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →